New York, NY (September 16, 2014) -- Five shareholders at the international law firm Greenberg Traurig, LLP have been named “Life Science Stars” in LMG Life Sciences 2014 guide.
The guide serves as a resource for in-house counsel identifying leading lawyers and firms in multiple practice areas. These practice areas include intellectual property, regulatory, transactional and non-IP litigation, which play important roles in guiding a product through its lifecycle.
The following shareholders were selected:
- Scott J. Bornstein, Intellectual Property (New York)
- Lori G. Cohen, Non-IP Litigation (Atlanta)
- David J. Dykeman, Intellectual Property (Boston)
- Eric D. Hargan, Regulatory (Chicago)
- Richard C. Pettus, Intellectual Property (New York)
Greenberg Traurig was also "Recommended" for General Patent Litigation, Hatch Waxman Patent Litigation and Product Liability.
According to its website, LMG Life Sciences’ research involved over 1,000 online surveys and interviews with nearly 600 attorneys in the United States, as well as a review of public information and feedback from clients within the industry. Through this qualitative process of peer opinion, market feedback and independent research led to our list of highest profile, most sought-after and best-attorneys working in life sciences.
About Greenberg Traurig’s Life Sciences and Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.